BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A
Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L, on behalf of the BoTULS investigators
Record ID 32005000950
English
Authors' recommendations:
The addition of botulinum toxin type A to an upper limb therapy programme for post stroke spasticity did not improve active upper limb function, but was useful for improving basic functional tasks (e.g. hand hygiene) and pain. However, treatment was not cost-effective at willingness-to-pay levels of NHS decision makers.
Details
Project Status:
Completed
URL for project:
http://www.hta.ac.uk/1408
Year Published:
2010
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Cost-Benefit Analysis
- Treatment Outcome
- Arm
- Muscle Spasticity
- Muscle Tonus
- Neuromuscular Agents
- Paresis
- Recovery of Function
- Stroke
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2010 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.